GDF2026 - FDA Commissioner Keynote
Conference on Generic Drugs · July 30, 2026
An unnamed agency official opened a two-day conference on generic drugs, stressing affordability, efforts to speed biosimilar and generic approvals, concerns about pharmacy benefit manager practices, and an "America First" approach to incentivize domestic generic manufacturing.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.